PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
September 10, 2025Journal of Precision Oncology

Complete Response to Sequential Peptide Receptor Radionuclide Therapy and Sunitinib in SDHB-mutated Metastatic Paraganglioma

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAmrit Kaur KalerSUSmrity UpadhyaySSShalaka Satpute

Discussion

Loading...

Member takes

Overview

A case of precision medicine shows complete resolution of metastatic paraganglioma using sunitinib and PRRT.

Key Points

  • Complete resolution of metastatic lesions was achieved after combining sunitinib with peptide receptor radionuclide therapy.
  • The patient had a confirmed SDHB mutation with a 71% allelic burden, contributing to a high malignancy risk.
  • The importance of genetic testing is emphasized, particularly in young patients with neuroendocrine tumors.
  • Personalized treatment approaches can significantly impact outcomes in rare cases of metastatic paraganglioma.

Cite This Study

Kaler et al. (2025) studied this question.

synapsesocial.com/papers/68c18f409b7b07f3a0615dc9https://doi.org/10.4103/jpo.jpo_5_25
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Role of integrated imaging in the diagnosis of an atypical and unresectable cardiac paraganglioma: a case report2023 · 2 citations
  2. 2Somatostatin Analogs in Clinical Practice: A Review2020 · 276 citations
  3. 3Mitochondrial fatty acid oxidation and the electron transport chain comprise a multifunctional mitochondrial protein complex2019 · 135 citations
  4. 4The Role of Mitochondria in Cellular Iron-Sulfur Protein Biogenesis: Mechanisms, Connected Processes, and Diseases2013 · 230 citations
  5. 5Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations2010 · 620 citations